TRIM
CELG

Thompson Rubinstein Investment Management’s Celgene Corp CELG Stock Holding History

Thompson Rubinstein Investment Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$4.24M Buy
44,963
+653
+1% +$57.1K 1.36% 30
2018
Q4 		$2.84M Buy
44,310
+3,863
+10% +$285K 1.05% 36
2018
Q3 		$3.62M Buy
40,447
+6,612
+20% +$584K 1.11% 36
2018
Q2 		$2.69M Buy
33,835
+11,099
+49% +$922K 0.9% 40
2018
Q1 		$2.03M Buy
22,736
+8,004
+54% +$768K 0.69% 41
2017
Q4 		$1.54M Buy
+14,732
New +$1.66M 0.51% 47

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Thompson Rubinstein Investment Management's CELG Position: Q1 2019 in Review

Thompson Rubinstein Investment Management increased its Celgene Corp (CELG) stake by 1.5% in Q1 2019, buying an estimated $57.1K and bringing the position to 44,963 shares worth $4.24M. The position accounts for 1.36% of the portfolio, ranked #30.

Thompson Rubinstein Investment Management first reported a position in CELG in Q4 2017 and has held it in 6 quarters since. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Thompson Rubinstein Investment Management held 44,963 shares of Celgene Corp worth $4.24M as of Q1 2019.
  • Thompson Rubinstein Investment Management bought 653 Celgene Corp shares in Q1 2019, an estimated $57.1K.
  • Celgene Corp made up 1.36% of Thompson Rubinstein Investment Management's portfolio in Q1 2019, its #30 holding.
  • Thompson Rubinstein Investment Management first reported a position in Celgene Corp in Q4 2017 and has held it in 6 quarters since.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Thompson Rubinstein Investment Management's 13F filing for Q1 2019, filed 4 Apr 2019.